17 / 22
Volume 6
Journal of Infectious Diseases & Therapy
Tropical & Bacterial Diseases 2018
December 05-06, 2018
Page 45
Notes:
conference
series
.com
Annual Conference on
Bacterial, Viral and Infectious Diseases
&
Neglected Tropical Diseases Congress: The Future Challenges
December 05-06, 2018 Dubai, UAE
Ghweil Ali Abdelrahman et al., J Infect Dis Ther 2018, Volume 6
DOI: 10.4172/2332-0877-C7-056
Reactivation of Herpesvirus
in patients with Hepatitis C treated with direct-acting anti viral agents
Ghweil Ali Abdelrahman and Mohamad M Helal
South Valley University, Egypt
W
e performed a case-series analysis of reactivation of
Herpesvirus
in patients with Hepatitis C virus (HCV) infection
treated with Direct-Acting Antiviral (DAA) agents. Eight cases were detected among 100 treated patients with direct
acting antiviral regimens in Qena University Hospital from June 2016 to June 2017.
Herpesvirus
was reactivated in 8 patients
who received DAA therapy. None of the cases had risk factor for HZ reactivation. The DAAs used regimens were sofosbuvir/
daclatasvir in 6 cases and sofosbuvir/ledipasvir in 2 cases. Immune changes that followHCV clearancemight lead to reactivation
of other viruses, such as
Herpesvirus
. Patients with HCV infection suspected of having
Herpesvirus
infection should be treated
promptly.
Biography
Ghweil Ali Abdelrahman was a Resident of (Tropical medicine and Gastroenterology) for three years .He worked as a Clinical demonstrator and assistant lecturer
of Tropical medicine and Gastroenterology, Sohag University. He was working as a Lecturer of Tropical medicine and Gastroenterology, South Valley University.
Currently, he is the Head of Tropical Medicine and Gastroenterology department, South Valley University. He is also a member of the European Society of Liver
Diseases (EASL).
alimena1@yahoo.com